RxDoctor Payments Data

Stephen Litman

Internal Medicine · Dresher, PANPI 1033115134

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,812 of the $3,711 with a category attached, or 75.8%. Eli Lilly accounts for 63.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $2,346 and has fallen 55.8% since, to $1,037 in 2025.

$3,711in general payments, 2019–2025

Across 43 payments — averaging $86.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Merck$1K
  • AbbVie$47
  • Astellas Pharma US Inc$36
  • Amarin Pharma, Inc.$30
  • Lilly USA, LLC$29
  • plus $137 from 6 others
$2,030,268in research payments, 2019–2025

Across 23 payments — averaging $88,273 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2M
  • Genentech, Inc.$10K

What the payments were for

  • Travel & lodging$2,81276%
  • Food & beverage$89924%

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,711 in reported general payments places this provider in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania →

Other internal medicine in Dresher

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →